Theravance Biopharma Inc (TBPH)
Net Income Growth
312.92%
TTM · Period ending:
TBPH Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported312.92%period ending
Latest reported312.92%period ending
TBPH TTM Net Income YoY % (-53.04% → 312.92%)
Year-over-year change
High-resolution chart · PNG
TBPH net income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Net Income Growth |
|---|---|
| 312.923% | |
| 296.3571% | |
| 287.6972% | |
| 159.3996% | |
| 128.5436% | |
| -30.2978% | |
| -2.2195% | |
| 13.3999% | |
| -105.2563% | |
| -105.1107% | |
| -106.3285% | |
| -106.7075% | |
| 955.8776% | |
| 701.2574% | |
| 537.3211% | |
| 476.5997% | |
| 61.5844% | |
| 46.9519% | |
| 28.2684% | |
| 20.8153% | |
| 2.1543% | |
| -11.2239% | |
| -17.5771% | |
| -29.0244% | |
| -21.591% | |
| -10.7216% | |
| -9.7117% | |
| 12.3781% | |
| 14.5038% | |
| 21.7959% | |
| 24.4849% | |
| 5.0994% | |
| -11.5088% | |
| -33.3594% | |
| -49.6861% | |
| -58.0698% | |
| -28.309% | |
| -17.5625% | |
| -4.6384% | |
| 16.6276% | |
| 13.1017% | |
| 17.1308% | |
| 23.1275% | |
| 6.9679% | |
| -2.6997% | |
| -19.2073% | |
| -51.6713% | |
| -53.3447% | |
| -53.0372% |